0001079973-21-000813.txt : 20210917 0001079973-21-000813.hdr.sgml : 20210917 20210817172812 ACCESSION NUMBER: 0001079973-21-000813 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPGEN INC CENTRAL INDEX KEY: 0001293818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 061614015 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 9717 KEY WEST AVENUE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-813-1260 MAIL ADDRESS: STREET 1: 9717 KEY WEST AVENUE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 CORRESP 1 filename1.htm

Correspondence

 

 

OpGen, Inc.

9717 Key West Avenue, Suite 100

Rockville, MD 20850

 

 

August 17, 2021

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549
Attention: Jeffrey Gabor

 

Re:     

OpGen, Inc.
Registration Statement on Form S-3

File Number 333-258646

 

Ladies and Gentlemen:

 

On behalf of OpGen, Inc., (the “Company”), and pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the above-referenced Registration Statement on Form S-3 be accelerated so that it will be declared effective at 4:00 p.m. on August 19, 2021, or as soon thereafter as is practicable.

Please direct any questions regarding the foregoing to the undersigned at (240) 813-1260 or to Peter Jaslow at (215) 864-8737.

  Sincerely,


/s/ Oliver Schacht
Oliver Schacht, PhD 
Chief Executive Officer
OpGen, Inc.

 

 

 

 

cc:Peter Jaslow, Esq.